MODIFIED RELEASE FORMULATIONS OF ANTIHYPERTENSIVE DRUGS
摘要
<p>Modified or extended release formulations containing propanolol compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved propanolol formulations such as INDERAL LA®.</p>
